tiprankstipranks
Trending News
More News >
Trimas Corp (TRS)
NASDAQ:TRS
Advertisement

Trimas (TRS) AI Stock Analysis

Compare
97 Followers

Top Page

TRS

Trimas

(NASDAQ:TRS)

Rating:72Outperform
Price Target:
$40.00
▲(8.78% Upside)
TriMas's overall stock score reflects strong financial performance and a positive earnings call, highlighting significant sales growth and improved profitability. The technical analysis suggests caution due to potential overbought conditions, while valuation concerns limit upside potential.
Positive Factors
Business Growth
TriMas Corp. is experiencing rapid growth in its packaging and aerospace business while Norris Cylinders is showing signs of a recovery.
Financial Performance
TRS reported second quarter sales of $274.8 million compared to the estimate of $252.3 million.
Partnership Expansion
The growth in aerospace is bound to take flight with an expanded relationship with Airbus.
Negative Factors
Cost Structure
The decline in EPS is related to TRS having a higher cost structure this year.
Demand Concerns
Demand is unlikely to remain at the same level to give TRS the ability to scale the packaging segment to the degree expected.
Tariffs Impact
The full year guidance remained unchanged due to tariffs being an unknown factor.

Trimas (TRS) vs. SPDR S&P 500 ETF (SPY)

Trimas Business Overview & Revenue Model

Company DescriptionTriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.
How the Company Makes MoneyTrimas generates revenue through the sale of its diverse product offerings across its business segments. Key revenue streams include the production and sale of packaging products, such as closures and containers, which serve the consumer goods and food and beverage industries. The Aerospace segment contributes revenue through the manufacture of precision-engineered components and fasteners for commercial and military aircraft. The Energy segment provides products and services tailored to the oil and gas industry, including valves and other critical components. Additionally, Trimas benefits from strategic partnerships with key industry players, which enhance its market reach and contribute to its overall earnings. The company's focus on operational efficiency and cost management also plays a significant role in its profitability.

Trimas Earnings Call Summary

Earnings Call Date:Jul 29, 2025
(Q2-2025)
|
% Change Since: 16.95%|
Next Earnings Date:Oct 23, 2025
Earnings Call Sentiment Positive
The earnings call reflects a strong overall performance with significant sales growth, margin improvements, and a positive outlook. The Aerospace segment, in particular, showed record performance, contributing to an increased full-year guidance. However, challenges remain in the Specialty Products and Packaging segments, alongside concerns regarding global tariffs.
Q2-2025 Updates
Positive Updates
Strong Sales Growth Across All Segments
TriMas reported consolidated net sales of $275 million for Q2 2025, an increase of more than 14% year-over-year, with organic growth of more than 13%.
Significant Margin Improvement
The operating profit increased by more than 50% compared to Q2 2024, reflecting a 300 basis points expansion in operating margin, notably led by the Aerospace segment.
Record Performance in Aerospace
The Aerospace segment reported a record sales quarter with revenue growth of 32%+, driven by strong market demand and acquisition-related sales, leading to a margin expansion of 650 basis points.
Raising Full Year 2025 Outlook
TriMas raised its full year sales growth guidance to 8% to 10% and adjusted EPS to $1.95 to $2.10, reflecting a 25% increase in EPS compared to 2024.
Negative Updates
Challenges in Specialty Products Segment
Sales in the Specialty Products segment decreased by 6.8% year-over-year, mainly due to the divestiture of Arrow Engine, despite Norris Cylinder's 13% sales growth.
Packaging Segment Growth Constraints
Although the Packaging segment achieved organic sales growth of nearly 8%, it faced slower growth in closures and flexibles product lines due to weakness in the food and beverage markets.
Potential Tariff Impact Concerns
The evolving global tariff environment is identified as a significant external factor, presenting uncertainties in customer order patterns and consumer demand.
Company Guidance
During the TriMas Corporation's second-quarter 2025 earnings call, the company provided updated guidance, reflecting strong financial performance and future expectations. TriMas reported consolidated net sales of $275 million, representing a year-over-year increase of over 14%, with organic growth of more than 13% when excluding currency effects and acquisitions. The company also achieved a 50% increase in operating profit compared to Q2 2024, and adjusted EBITDA grew by 31% to nearly $48 million, with margins improving by 220 basis points to 17.4%. Adjusted earnings per share rose to $0.61, marking a 42% growth year-over-year. For the full year 2025, TriMas raised its sales growth guidance to 8-10% and adjusted earnings per share to a range of $1.95 to $2.10, expecting a 25% increase in EPS compared to 2024. This optimistic outlook is backed by strong performance across all segments, particularly in Aerospace, where record sales and significant margin expansion were noted.

Trimas Financial Statement Overview

Summary
Trimas shows solid financial health with consistent revenue growth and improved profitability margins. The balance sheet reflects low leverage, supporting financial stability. Cash flow analysis indicates robust operational cash generation, though capital expenditures affect free cash flow. Overall, the company is well-positioned for continued growth and stability.
Income Statement
75
Positive
Trimas shows a positive revenue growth trend with a 5.1% increase in TTM (Trailing-Twelve-Months) compared to the prior year. The company's gross profit margin is stable at 21.3% for TTM, albeit slightly lower than previous years. Net profit margin improved to 3.4% in TTM, indicating enhanced profitability. EBIT margin rose to 6.0%, suggesting better operational efficiency, while EBITDA margin improved significantly to 11.7%, reflecting strong cash earnings potential.
Balance Sheet
70
Positive
Trimas maintains a healthy equity ratio of 49.3% in TTM, indicating solid equity backing. The debt-to-equity ratio stands at 0.07, demonstrating low leverage and financial stability. Return on equity is modest at 4.6% in TTM, showing potential for higher profitability. The balance sheet reflects a stable financial position with manageable debt levels.
Cash Flow
68
Positive
The cash flow analysis shows a strong operating cash flow to net income ratio of 2.43 in TTM, indicating effective cash generation from operations. Free cash flow to net income ratio is 0.83, demonstrating decent cash flow conversion. Free cash flow growth of 102.9% in TTM highlights significant improvement, though capital expenditures slightly constrain free cash flow.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue925.01M893.55M883.83M857.11M769.97M
Gross Profit199.46M201.32M208.30M217.19M182.08M
EBITDA47.19M124.10M140.86M158.19M-38.28M
Net Income24.25M40.36M66.17M57.31M-79.76M
Balance Sheet
Total Assets1.32B1.34B1.30B1.30B1.19B
Cash, Cash Equivalents and Short-Term Investments23.07M34.89M112.09M140.74M73.95M
Total Debt442.84M443.25M444.02M445.72M384.64M
Total Liabilities656.88M658.71M653.17M672.79M609.63M
Stockholders Equity667.30M682.95M651.83M630.85M584.25M
Cash Flow
Free Cash Flow12.82M33.97M26.61M89.16M86.93M
Operating Cash Flow63.78M88.16M72.57M134.22M127.41M
Investing Cash Flow-46.96M-134.42M-55.04M-79.18M-232.07M
Financing Cash Flow-28.64M-30.94M-46.18M11.75M6.14M

Trimas Technical Analysis

Technical Analysis Sentiment
Positive
Last Price36.77
Price Trends
50DMA
30.75
Positive
100DMA
27.09
Positive
200DMA
25.88
Positive
Market Momentum
MACD
1.80
Negative
RSI
71.28
Negative
STOCH
86.15
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRS, the sentiment is Positive. The current price of 36.77 is above the 20-day moving average (MA) of 34.33, above the 50-day MA of 30.75, and above the 200-day MA of 25.88, indicating a bullish trend. The MACD of 1.80 indicates Negative momentum. The RSI at 71.28 is Negative, neither overbought nor oversold. The STOCH value of 86.15 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TRS.

Trimas Risk Analysis

Trimas disclosed 26 risk factors in its most recent earnings report. Trimas reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Trimas Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
$1.50B40.575.36%0.44%6.72%-6.68%
69
Neutral
$4.39B14.6337.35%2.53%-2.00%-18.50%
66
Neutral
$4.54B30.973.98%4.54%0.90%-118.86%
61
Neutral
$17.23B11.50-5.97%3.09%1.49%-16.00%
60
Neutral
$614.27M62.243.43%3.35%1.11%-74.94%
57
Neutral
$2.31B-69.06%10.47%8.39%72.18%
54
Neutral
$2.11B-18.69%-3.36%11.88%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRS
Trimas
36.77
12.87
53.85%
MYE
Myers Industries
16.12
2.18
15.64%
OI
O-I Glass
13.37
1.11
9.05%
SEE
Sealed Air
31.58
-1.35
-4.10%
SON
Sonoco Products
46.25
-2.35
-4.84%
AMBP
Ardagh Metal Packaging
3.82
0.86
29.05%

Trimas Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
TriMas Appoints Thomas Snyder as New CEO
Neutral
Jun 9, 2025

On June 3, 2025, TriMas Corporation’s Board of Directors appointed Thomas Snyder as the new President and CEO, effective June 23, 2025, succeeding Thomas Amato. Snyder brings nearly 35 years of experience from Silgan Holdings Inc., and his appointment includes a comprehensive compensation package. The transition is expected to impact the company’s leadership dynamics and operational strategies, with Amato transitioning to a Special Advisor role until June 30, 2025.

The most recent analyst rating on (TRS) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Trimas stock, see the TRS Stock Forecast page.

Executive/Board ChangesShareholder Meetings
TriMas Holds Annual Shareholders Meeting, Elects Directors
Neutral
May 15, 2025

On May 14, 2025, TriMas Corporation held its Annual Meeting of Shareholders, where 37,408,528 shares were represented, constituting a quorum. During the meeting, shareholders elected directors Jeffrey A. Fielkow and Adrianne W. Shapira for a three-year term, ratified Deloitte & Touche LLP as the independent public accounting firm for 2025, and approved the compensation for the Company’s Named Executive Officers.

The most recent analyst rating on (TRS) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Trimas stock, see the TRS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025